iSelect Fund
Venture capitalSt. Louis Β· SeedβLate Stage Β· 9 people tracked
Investment thesis
iSelect targets early-stage companies that have demonstrated traction and moved beyond concept to commercialization. The firm focuses on healthcare, food and agriculture, resource efficiency, and B2B technology sectors, primarily in the Midwest. iSelect emphasizes founder passion, clear problem definition, and revolutionary solutions. The firm does not lead rounds but co-invests alongside sophisticated investors, providing both capital and strategic support through talent and customer access. Companies must demonstrate meaningful traction through customer orders, R&D investments, or grant funding, with clear milestones and exit planning.
Source: firm website, verified Jul 21, 2026.
Team Β· 9 people
from the firm's websiteWhat they invest in
from 16 of 114 portfolio companiesBiotech Γ11Healthtech Γ7Medical Devices Γ7AgTech Γ4AI & Machine Learning Γ3Deep Tech Γ3Digital Health Γ3Climate Tech Γ2
HQs:United StatesΓ8
Investments Β· showing 60 of 114
founders shown can be your intro pathBenson Hill develops genetically optimized soy seed varieties using AI-driven plant science, targeting agricultural producers seeking more nutritious, sustainable, and energy-dense crop solutions.
AgTechAI & Machine LearningNew Materials
Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response. The company serves oncology and precision medicine markets by enabling more accurate patient-to-therapy matching.
AI & Machine LearningBiotechHealthtechMedical DevicesSt. Louis, US
Dave Messina(Founder/COO)inJarret Glasscock(Founder & CEO)in
Faeth Therapeutics develops PIKTOR, an oral multi-node inhibitor targeting the PI3K/AKT/mTOR pathway for cancer treatment, currently in clinical trials for endometrial and breast cancer.
BiotechDigital HealthMedical Devices
Flywheel provides a platform for organizing, managing, and sharing medical imaging data. The company serves pharmaceutical companies, medical device manufacturers, AI developers, and academic medical centers to accelerate clinical trials, advance AI development, and streamline research workflows.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US
Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)
Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer. The company serves healthcare providers and patients seeking advanced diagnostic solutions in the medical diagnostics and cancer detection sector.
BiotechDigital HealthHealthtechMedical DevicesSt. Louis, US
Andrew Barnell(Chief Executive Officer & Co-founder)Erica Barnell(Co-founder)
HepaTx develops stem cell-based hepatocyte therapies for liver disease treatment as an alternative to organ transplantation. The company targets niche liver disease indications including alpha-1 antitrypsin deficiency, phenylketonuria, and non-alcoholic steatohepatitis.
BiotechHealthtechMedical DevicesSan Francisco, US
Eric Schuur(Chief Executive Officer, Co-Founder)in
Immunophotonics is a clinical-stage biotech company developing novel treatments for solid-tumor cancers and infectious diseases by combining tumor ablation with systemic cancer immunotherapy. The company's intellectual property platform includes IP-001, designed to transform routine ablation procedures into systemically active cancer immunotherapy.
BiotechDeep TechDigital HealthMedical DevicesSt. Louis, US
Dr. Hode(Co-Founder & Senior Fellow)Mr. Alleruzzo(Co-Founder & Director)Dr. Chen(Co-Founder)Dr. Robert Nordquist(Co-Founder)
Kula Bio develops bacterial propagation and feeding systems that enhance the nitrogen-fixing capabilities of naturally occurring microbes for agricultural applications. The company applies microbial technology originally derived from bionic leaf research to improve crop and turf production.
AgTechBiotech
Frequently asked questions
- What stage does iSelect Fund invest at?
- iSelect Fund invests at the Seed, Series A, Series B, Late Stage stages.
- What is iSelect Fund's typical check size?
- iSelect Fund typically writes checks of $250K.
- What sectors does iSelect Fund focus on?
- iSelect Fund focuses on AgTech, FoodTech, Healthtech, SaaS.
- Where is iSelect Fund located?
- iSelect Fund is headquartered in St. Louis, US.
- Does iSelect Fund lead rounds?
- iSelect Fund typically participates in rounds rather than leading them.
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Lerer Hippeau is an early-stage venture capital firm focused on identifying and backing founders before they achieve prominence. The firm actively invests across multiple sectors including AI/ML, healthtech, fintech, enterprise software, and other emerging technology areas.
JVP is a venture capital firm managing approximately $2 billion in assets that focuses on investing in transformative technologies across multiple sectors. The firm builds and scales category-defining companies internationally, with expertise in guiding portfolio companies from early stages to public offerings and major acquisitions.
Cultivation Capital invests in early-stage companies across life sciences, healthcare technology, software, agriculture, and geospatial technologies from Series Seed through Series B, leveraging a network of partners to support growth.
Red Alpine is a venture capital firm focused on identifying and empowering GameChangers at the confluence of software and science. The firm invests in transformative technologies and scientific breakthroughs, prioritizing companies that tackle pressing global challenges across healthcare, AI, fintech, synthetic biology, and sustainability.